busulfan

(redirected from Busulfex)
Also found in: Dictionary, Medical.

busulfan

[‚byü′səl·fən]
(pharmacology)
CH3SO2O(CH2)4OSO2CH3 Crystals with a melting point of 114-118°C; soluble in acetone at 25°C; used as an antineoplastic drug.
References in periodicals archive ?
OPDC), will investigate clinical studies for potential new indications for IV Busulfex.
OPDC), will initiate clinical studies to investigate potential new indications for IV Busulfex.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks and Cardene, Busulfex and Nuvion are registered U.
This press release contains forward-looking statements, including regarding PDL's plans to change its strategic focus; sell its commercial assets, including its Cardene, Retavase and Busulfex product rights, and ularitide development-stage cardiovascular product; an anticipated workforce reduction; and the advancement of PDL's clinical antibody pipeline, each of which involves risks and uncertainties.
Busulfex is used as a conditioning regimen prior to hematopoietic progenitor cell transplantation.
Busulfex, which is used in preparative regimens for bone marrow transplantation, increased its market share to 55 percent in transplants where busulfan-based regimens are used.
Unfortunately, instead of channeling this royalty stream into earnings generation and expeditious product development, you made what we consider to be an ill- conceived purchase of ESP Pharma for $500M to gain access to products Cardene IV, Retavase and Busulfex.
Orphan Medical has partnered with Pierre Fabre Medicament to obtain final approval and market Busulfex in Europe.
In addition to the approval and launch of Xyrem in 2002, we set record revenues led by Busulfex and Antizol, made important additions to our team, expanded our strategic capabilities, and laid the groundwork for continued expansion of our product pipeline.
NOTE: PDL BioPharma, the PDL BioPharma logo, Retavase and Busulfex are considered trademarks and Cardene and Nuvion are registered U.
Awareness of the benefits of Busulfex is growing in the United States and Canada where the drug provides an alternative to oral busulfan and total body irradiation.
Of this, net sales of Cardene IV, Retavase and IV Busulfex for the year totaled $109.